Evidence map›Paper›PMID 42448306›Full record

ArticleBiochemistry2026

Fluorescence-Activated Cell Sorting Enables Rapid Screening of RNA Polymerase-Promoter Interaction in E. coli.

Lilian Göldel, Ralph Krafczyk, Romina Rathberger, Thomas Brück, Hagen Richter

Abstract read
In one paragraph

Article in Biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lilian GöldelWacker Chemie AG , Munich, Bavaria81379, Germany.
Ralph KrafczykWacker Chemie AG , Munich, Bavaria81379, Germany.
Romina RathbergerWacker Chemie AG , Munich, Bavaria81379, Germany.
Thomas BrückWerner Siemens-Chair of Synthetic Biotechnology, TUM School of Natural Sciences, Technical University of Munich (TUM), Garching, Bavaria85748, Germany.
Hagen RichterWacker Chemie AG , Munich, Bavaria81379, Germany.ORCID 0009-0003-6450-7601

Funding

Wacker NA
6 · The paper itself

Abstract

RNA polymerases are essential in the enzymatic synthesis of RNA via in vitro transcription. The resulting mRNA transcripts have been investigated more and more as therapeutics in clinical studies. Therefore, it is important that these enzymes possess a high specificity. Despite their utility, many commercially available RNA polymerases are limited by their tendency to generate abortive transcripts and undesired byproducts. To ensure high specificity, optimal pairing between the RNA polymerase and its cognate promoter is vital. However, current promoter characterization techniques remain laborious and time-consuming, thereby limiting efficient and rapid RNA-polymerase applications. In this work, we describe a high-throughput strategy for rapid promoter identification using a two-plasmid screening platform in E. coli. Cell populations are analyzed and sorted via fluorescence-activated cell sorting (FACS), followed by sequence verification. Functionality of the screening platform was validated via cell sorting, based on high fluorescence, of a mixed population containing T7 RNA polymerase paired with three different promoters. Moreover, the screening system was evaluated by using two recently identified RNA polymerases in combination with their respective cognate promoters. This proof-of-concept facilitates the identification of both RNA polymerase and promoter. Further, it substantially accelerates promoter characterization, thereby supporting improvements regarding mRNA manufacturing workflows.

Indexed as

DNA-Directed RNA PolymerasesEscherichia coliFlow CytometryPromoter Regions, GeneticViral ProteinsTranscription, Geneticbacteriophage T7 RNA polymeraseDNA-Directed RNA PolymerasesViral Proteins

Identifiers

PMID42448306
PMCPMC13445594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.